Search

Search Results

• Pulmonary embolism - assessment of risk factors and emboli locations

  Mateusz Komisarczuk, Michał Kaczor, Ewa Kopyto, Mateusz Woch, Piotr Piech

  153-167

  2020-02-27
• Assessment of the effects of low molecular heparins in pulmonary embolism prophylaxis

  Michał Piwoński, Klaudia Żak, Piotr Piech, Małgorzata Neścior

  310-318

  2019-05-22
• Epicardial adipose tissue and right ventricular dysfunction in patients with acute pulmonary embolism

  Grzegorz Staśkiewicz, Piotr Piech, Elżbieta Siek, Piotr Przybylski, Jacek Baj, Piotr Olechowski, Ryszard Maciejewski, Elżbieta Czekajska-Chehab, Andrzej Drop

  519-524

  2019-03-24
• Retrospective analysis of treatment outcomes in polytrauma patients with multiple long bone fractures of lower extremities

  Sergii Dubrov, Olexandr Burianov, Taras Omelchenko, Myroslav Vakulych, Dmytro Miasnikov, Volodymyr Lianskorunskyi

  327-339

  2020-02-28
• Pulmonary embolism in COVID-19

  V. Ilyina-Stohniienko, Yu. Kharchenko, A. Zaretska, A. Savchuk, A. Kolotvin

  285-291

  2022-02-28
• Non-vitamin K oral anticoagulant in the prevention and treatment of venous thromboembolism. Why betrixaban is different?

  Łukasz Wołowiec, Daniel Rogowicz, Krystian Kałużny, Anna Kałużna, Walery Zukow

  836-846

  2017-08-31
• ANTICOAGULANT TREATMENT OF AF: FOCUS ON THE WARFARIN DOSAGE

  Y. Kovbasniuk, O. Plenova

  323-326

  2015-10-31
• Effect of physical activity on peak expiratory flow and the 6-minute walk test

  Klaudia Jakubowska, Magdalena Pawelec-Winiarz, Michał Włosiński, Michał Cichosz

  323-330

  2022-07-01